Colin O'rourke

Oral desensitization therapy for peanut allergy induces dynamic changes in peanut‐specific immune responses

V. Gersuk, B. Vickery, Charlie Quinn, 2022, Allergy.

Autoantibody Reversion: Changing Risk Categories in Multiple-Autoantibody–Positive Individuals

C. Greenbaum, C. Speake, H. Bahnson, 2020, Diabetes Care.

Response to Comment on So et al. Autoantibody Reversion: Changing Risk Categories in Multiple-Autoantibody–Positive Individuals. Diabetes Care 2020;43:913–917

C. Greenbaum, C. Speake, H. Bahnson, 2020, Diabetes Care.

IgE to epitopes of Ara h 2 enhance the diagnostic accuracy of Ara h 2‐specific IgE

N. Barbosa-Morais, L. James, S. Maleki, 2020, Allergy.

Clinical and Virologic Outcomes Following Initiation of Antiretroviral Therapy Among Seroconverters in the MTN-020/ASPIRE Phase III Trial of the Dapivirine Vaginal Ring.

Ashley J. Mayo, J. Baeten, J. Mellors, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Autoreactive T cell receptors with shared germline-like α chains in type 1 diabetes

Kaitlin J. Flynn, P. Linsley, V. Gersuk, 2021, JCI insight.

Patterns of Practice and Improvements in Survival Among Patients With Stage 2/3 Rectal Cancer Treated With Trimodality Therapy

Vlad V. Simianu, H. Kennecke, H. Bahnson, 2022, JAMA oncology.

Characterising the age-dependent effects of risk factors on type 1 diabetes progression

A. Steck, C. Greenbaum, J. Wentworth, 2022, Diabetologia.

Biomarkers of severity and threshold of allergic reactions during oral peanut challenges

G. Roberts, G. Lack, M. Plaut, 2020, The Journal of allergy and clinical immunology.

Defining the window of opportunity and the target populations to prevent peanut allergy.

G. Roberts, G. Lack, E. Brittain, 2022, Journal of Allergy and Clinical Immunology.

A standardized metric to enhance clinical trial design and outcome interpretation in type 1 diabetes

C. Speake, Colin O'rourke, Sandra Lord, 2023, Nature communications.